foxo4 dri peptide senolytic 2023 FOXO4-DRI FOXO4-DRI Research Peptide – 15mg
FOXO4 DRI Research Peptide 15mg FOXO4 DRI 10mg The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



